Dependence of FDG uptake on tumor microenvironment

被引:170
作者
Pugachev, A [1 ]
Ruan, S [1 ]
Carlin, S [1 ]
Larson, SM [1 ]
Campa, J [1 ]
Ling, CC [1 ]
Humm, JL [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 62卷 / 02期
关键词
hypoxia; FDG; tumor proliferation; glucose metabolism; PET tumor tracers;
D O I
10.1016/j.ijrobp.2005.02.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the factors affecting the F-18-fluorodeoxyglucose (F-18-FDG) uptake in tumors at a microscopic level, by correlating it with tumor hypoxia, cellular proliferation, and blood perfusion. Methods and Materials: Nude mice bearing Dunning prostate tumors (R3327-AT) were injected with F-18-FDG and pimonidazole, bromodeoxyuridine, and, 1 min before sacrifice, with Hoechst 33342. Selected tumor sections were imaged by, phosphor plate autoradiography, while adjacent sections were used to obtain the images of the spatial distribution of Hoechst 33342, pimonidazole, and bromodeoxyuridine. The images were co-registered and analyzed on a pixel-by-pixel basis. Results: Statistical analysis of the data obtained from these tumors demonstrated that F-18-FDG uptake was positively correlated with pimonidazole staining intensity in each data set studied. Correlation of FDG uptake with bromodeoxyuridine staining intensity was always negative. In addition, FDG uptake was always negatively correlated with the staining intensity of Hoechst 33342. Conclusions: For the Dunning prostate tumors studied, FDG uptake was always positively correlated with hypoxia and negatively correlated with both cellular proliferation and blood flow. Therefore, for the tumor model studied, higher FDG uptake is indicative of tumor hypoxia, but neither blood flow nor cellular proliferation. © 2005 Elsevier Inc.
引用
收藏
页码:545 / 553
页数:9
相关论文
共 24 条
[1]  
Avril N, 2001, J NUCL MED, V42, P9
[2]   A METHOD TO MEASURE THE DURATION OF DNA-SYNTHESIS AND THE POTENTIAL DOUBLING TIME FROM A SINGLE SAMPLE [J].
BEGG, AC ;
MCNALLY, NJ ;
SHRIEVE, DC ;
KARCHER, H .
CYTOMETRY, 1985, 6 (06) :620-626
[3]  
Brown RS, 1996, J NUCL MED, V37, P1042
[4]  
Burgman P, 2001, J NUCL MED, V42, P170
[5]   Using positron emission tomography with [18F]FDG to predict tumor behavior in experimental colorectal cancer [J].
Burt, BM ;
Humm, JL ;
Kooby, DA ;
Squire, OD ;
Mastorides, S ;
Larson, SM ;
Fong, YM .
NEOPLASIA, 2001, 3 (03) :189-195
[6]  
CLAVO AC, 1995, J NUCL MED, V36, P1625
[7]  
Clavo AC, 1996, J NUCL MED, V37, P502
[8]  
Dearling JLJ, 2004, J NUCL MED, V45, P101
[10]   REGULATION OF GLUCOSE-TRANSPORTER GENE-EXPRESSION INVITRO AND INVIVO [J].
KAHN, BB ;
FLIER, JS .
DIABETES CARE, 1990, 13 (06) :548-564